arginine has been researched along with acipimox in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boffano, GM; Camanni, F; Ghigo, E; Grottoli, S; Maccario, M; Oleandri, SE; Procopio, M; Taliano, M | 1 |
| Casanueva, FF; Cordido, F; de Vries, WR; Dieguez, C; Koppeschaar, HP; van Dam, PS; van Thiel, E; Veldhuyzen, BF | 1 |
| Cattaneo, A; Cavagnini, F; Fatti, LM; Filippini, B; Grasso, A; Moro, M; Orsini, F; Pecori Giraldi, F; Scacchi, M | 1 |
1 trial(s) available for arginine and acipimox
| Article | Year |
|---|---|
Diagnosis of growth hormone deficiency after pituitary surgery: the combined acipimox/GH-releasing hormone test.
Topics: Adenoma; Adolescent; Adult; Aged; Area Under Curve; Arginine; Fatty Acids, Nonesterified; Female; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Insulin; Male; Middle Aged; Pituitary Neoplasms; Predictive Value of Tests; Pyrazines; Stimulation, Chemical | 2003 |
2 other study(ies) available for arginine and acipimox
| Article | Year |
|---|---|
Effects of acipimox, an antilipolytic drug, on the growth hormone (GH) response to GH-releasing hormone alone or combined with arginine in obesity.
Topics: Adult; Arginine; Fatty Acids, Nonesterified; Female; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Hypolipidemic Agents; Obesity; Pyrazines | 1996 |
The diagnosis of GH deficiency in obese patients: a reappraisal with GHRH plus arginine testing after pharmacological blockade of lipolysis.
Topics: Adult; Aged; Arginine; Female; Growth Hormone-Releasing Hormone; Human Growth Hormone; Humans; Hypolipidemic Agents; Hypopituitarism; Insulin; Insulin-Like Growth Factor I; Linear Models; Lipolysis; Male; Middle Aged; Obesity; Pyrazines | 2010 |